Skip to main content
TipRanks
Go Ultimate75% OFF

COSCIENS Biopharma (CSCIF) Ratios

903 Followers

COSCIENS Biopharma Ratios

CSCIF's free cash flow for Q3 2026 was $1.42M. For the 2026 fiscal year, CSCIF's free cash flow was decreased by $-107.90K and operating cash flow was $1.53M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Mar 25Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio3.183.328.017.889.12
Quick Ratio2.822.957.137.848.88
Cash Ratio2.022.277.497.188.41
Solvency Ratio-0.53-0.63-0.190.160.10
Operating Cash Flow Ratio-2.39-2.02-3.77-1.94-1.10
Short-Term Operating Cash Flow Coverage-40.170.00-57.31-50.12-37.72
Net Current Asset Value$ -6.08M$ 2.07M$ 17.55M$ 35.24M$ 43.70M
Leverage Ratios
Debt-to-Assets Ratio0.100.070.090.070.00
Debt-to-Equity Ratio0.560.180.190.110.00
Debt-to-Capital Ratio0.360.150.160.100.00
Long-Term Debt-to-Capital Ratio0.000.000.070.040.03
Financial Leverage Ratio5.582.662.031.571.51
Debt Service Coverage Ratio-24.45-105.22-38.71-44.428.38
Interest Coverage Ratio-62.15-108.71-140.54-160.58-72.79
Debt to Market Cap0.100.000.050.030.01
Interest Debt Per Share6.590.940.720.810.06
Net Debt to EBITDA0.551.041.703.04-22.85
Profitability Margins
Gross Profit Margin35.30%49.33%95.06%97.22%98.29%
EBIT Margin-139.25%-157.46%-400.36%77.17%51.44%
EBITDA Margin-123.41%-140.70%-400.00%-272.36%54.20%
Operating Profit Margin-139.25%-146.27%-400.36%-272.64%-164.85%
Pretax Profit Margin-138.01%-158.81%-367.99%-402.96%-161.16%
Net Profit Margin-138.14%-159.68%-78.93%57.46%50.18%
Continuous Operations Profit Margin-138.14%-159.68%-78.93%57.46%50.18%
Net Income Per EBT100.10%100.55%21.45%-14.26%-31.14%
EBT Per EBIT99.11%108.57%91.91%147.80%97.76%
Return on Assets (ROA)-49.27%-43.65%-9.59%5.78%3.30%
Return on Equity (ROE)-274.82%-116.32%-19.51%9.06%4.98%
Return on Capital Employed (ROCE)-59.73%-50.36%-55.45%-31.39%-11.99%
Return on Invested Capital (ROIC)-59.02%-49.87%-49.62%-31.05%-11.84%
Return on Tangible Assets-49.27%-43.65%-9.59%5.79%3.70%
Earnings Yield-483.00%-73.70%-9.43%5.26%1.60%
Efficiency Ratios
Receivables Turnover6.063.8815.542.653.14
Payables Turnover6.642.020.120.080.10
Inventory Turnover3.781.810.060.690.05
Fixed Asset Turnover0.780.8714.1926.1127.40
Asset Turnover0.360.270.120.100.07
Working Capital Turnover Ratio0.620.390.110.100.12
Cash Conversion Cycle101.70115.413535.30-4068.063720.90
Days of Sales Outstanding60.2294.0823.49137.57116.40
Days of Inventory Outstanding96.47202.196579.78532.397392.40
Days of Payables Outstanding54.99180.853067.974738.033787.89
Operating Cycle156.69296.266603.28669.967508.79
Cash Flow Ratios
Operating Cash Flow Per Share-24.51-5.64-3.53-2.82-1.87
Free Cash Flow Per Share-26.56-6.09-3.53-2.82-2.01
Dividend Paid and CapEx Coverage Ratio-12.00-12.55-900.95-1243.64-13.43
Capital Expenditure Coverage Ratio-12.00-12.55-900.95-1243.64-13.43
Operating Cash Flow Coverage Ratio-4.02-6.31-5.05-3.54-53.30
Operating Cash Flow to Sales Ratio-1.13-1.52-3.81-2.43-1.63
Free Cash Flow Yield-428.03%-75.72%-45.54%-22.22%-5.58%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.21-1.36-4.046.7927.05
Price-to-Sales (P/S) Ratio0.292.178.3710.9231.44
Price-to-Book (P/B) Ratio0.571.582.071.723.12
Price-to-Free Cash Flow (P/FCF) Ratio-0.23-1.32-2.20-4.50-17.94
Price-to-Operating Cash Flow Ratio-0.25-1.43-2.20-4.50-19.27
Price-to-Earnings Growth (PEG) Ratio-0.00-0.010.020.170.27
Enterprise Value Multiple0.32-0.50-0.39-0.9735.16
Enterprise Value-2.97M6.69M7.01M14.86M100.22M
EV to EBITDA0.32-0.50-0.39-0.9735.16
EV to Sales-0.390.701.562.6419.05
EV to Free Cash Flow0.32-0.43-0.41-1.09-10.87
EV to Operating Cash Flow0.34-0.46-0.41-1.09-11.68
Tangible Book Value Per Share10.905.103.757.369.62
Shareholders’ Equity Per Share10.905.103.757.3711.53
Tax and Other Ratios
Effective Tax Rate-0.00-0.010.09-0.040.01
Revenue Per Share21.693.710.931.161.14
Net Income Per Share-29.97-5.93-0.730.670.57
Tax Burden1.001.010.21-0.14-0.31
Interest Burden0.991.010.92-5.22-3.13
Research & Development to Revenue0.390.873.012.221.25
SG&A to Revenue1.341.091.941.461.38
Stock-Based Compensation to Revenue0.000.050.040.010.00
Income Quality0.820.954.82-4.22-3.25

Currency in USD